Bright Minds Biosciences Inc. (DRUG) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 580.75M |
| Enterprise Value | 497.97M |
| P/E Ratio | -26.34 |
| PEG Ratio | 0.24 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.78 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -12.28 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.09 |
| Return On Equity | -0.21 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -12.15M |
| Net Income | -12.23M |
| Diluted EPS | -1.78 |
| Total Cash | 309.47M |
| Total Cash/Share | 32.19 |
| Total Debt | 82,071 |
| Total Debt/Equity | 0 |
| Current Ratio | 81.48 |
| Book Value Per Share | 32.07 |
| 52-Week Change | 134.37 |
| 52-Week High | 123.75 |
| 52-Week Low | 23.18 |
| Moving Average 50 Days | 80.09 |
| Moving Average 200 Days | 72.92 |
| Average Volume | 277,172 |
| Shares Outstanding | 7.76M |
| % Held by Institutions | 118.39 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | July 14, 2023 |